{{Rsnum
|rsid=2181540
|Gene=MCF2L
|Chromosome=13
|position=113098850
|Orientation=minus
|GMAF=0.1281
|Gene_s=MCF2L
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 77.9 | 19.5 | 2.7
| HCB | 87.6 | 12.4 | 0.0
| JPT | 88.5 | 11.5 | 0.0
| YRI | 58.5 | 34.7 | 6.8
| ASW | 77.2 | 22.8 | 0.0
| CHB | 87.6 | 12.4 | 0.0
| CHD | 95.3 | 4.7 | 0.0
| GIH | 56.4 | 40.6 | 3.0
| LWK | 40.9 | 50.9 | 8.2
| MEX | 72.4 | 25.9 | 1.7
| MKK | 34.7 | 49.3 | 16.0
| TSI | 66.7 | 27.5 | 5.9
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23381943
  |Trait=End-stage coagulation
  |Title=Ischemic stroke is associated with the ABO locus: the EuroCLOT study.
  |RiskAllele=T
  |Pval=1E-46
  |OR=.83
  |ORtxt=[0.72-0.95] unit increase
  |OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}